News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Market source Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Viking Holdings Ltd (VIK) stock closed down by 8.00% on August 14th, primarily due to profit-taking ahead of its Q2 earnings report and concerns over its valuation and debt levels. Despite the intraday decline, the company's long-term outlook remains strong, driven by capacity expansion …
The Canada Pension Plan Investment Board has reported a 3.5% ownership stake in Viking Holdings Ltd., holding 11,244,744 ordinary shares. This ownership includes sole voting and dispositive power over these shares, based on Viking's approximately 318,386,000 ordinary shares outstanding as of March 31, 2026. …
Viking Holdings (VIK) stock dropped 4.1% today, likely due to a combination of broader cruise-sector caution and pre-earnings positioning, rather than specific negative company news. Investors are reassessing cruise stocks ahead of Viking's Q2 2026 earnings report on August 19, amidst concerns about booking …
In its upcoming report, Viking Holdings (VIK) is predicted by Wall Street analysts to post quarterly earnings of $1.25 per share, reflecting an increase of 26.3% compared to the same period last year. Revenues are forecasted to be $2.13 billion, representing a year-over-year increase …
This article provides an analysis of Viking Therapeutics Inc. (NASDAQ: VKTX) price dynamics, highlighting a neutral near-term sentiment that could moderate mid-term weakness. It identifies a mid-channel oscillation pattern and an exceptional short setup with a 50.5:1 risk-reward ratio. The analysis also details institutional …
Stifel has increased its price target for Viking Holdings (NYSE:VIK) to $125 from $105, maintaining a Buy rating, citing healthy booking patterns for 2027 and 2028 with accelerated demand since May. The firm noted that 2027 pricing is expected to be up in the …
Viking Holdings recently expanded its river cruise fleet by adding the Viking Ptah, an 82-guest vessel purpose-built for Nile sailings, reinforcing its growth strategy in Egypt's high-end market. While this delivery validates the company's planned capacity expansion and supports its investment narrative of increasing …
Viking Acquisition Corp I (VACI) reported a net income of $838K for the third quarter ended June 30, 2026, with an EPS of $0.03. For the six months ended the same date, net income was $2.573M and EPS was $0.08. As a blank-check company …
Viking Holdings (NYSE:VIK) is projected for significant growth, with analysts forecasting 19.9% earnings and 13.5% revenue growth per annum, alongside a strong future return on equity of 60.7%. The company continues to expand its fleet across river, ocean, and expedition segments, introducing new ships …
Viking Holdings (VIK) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare …
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Viking Holdings (NYSE:VIK) has expanded its river cruise fleet with the delivery of Viking Ptah in Egypt and Viking Dagur in Europe. The …
JP Morgan has maintained an "Overweight" rating for Viking Therapeutics (VKTX) but lowered its price target from $75 to $65, reflecting cautious optimism amid challenges in the biotechnology sector. The company has a GF Score™ of 34/100, indicating below-average performance in key financial metrics, …
Viking Therapeutics (VKTX) recently expanded its financing options by filing a $500 million at-the-market follow-on offering and an omnibus shelf registration, following a Q2 2026 net loss of US$128.02 million and previous fundraising of US$159.59 million. This move aims to provide balance sheet flexibility …
J.P. Morgan has reiterated its Buy rating for Viking Therapeutics (VKTX.US) but has revised its target price downwards to $65. This adjustment reflects an updated outlook on the company's valuation while still recommending the stock to investors.
Investing.com -- Hospitality software firm Mews has been granted an Electronic Money Institution license by De Nederlandsche Bank, allowing it to hold hotel funds directly rather than routing them through third-party providers, Investing.com has learned. The license was issued to Mews Financial Services B.V., …
Sharemaestro market context Price below Trend Line 52 weeks -30.5%Viking announced it has taken delivery of its newest river ship, the Viking Ptah, in Cairo, Egypt. This vessel, designed for 82 guests, will operate on Viking's 12-day Pharaohs & Pyramids itinerary on the Nile River. The delivery is part of Viking's significant long-term …
Search by ticker symbol or company name and select a result to open its chart.